DD214134A5 - Verfahren zur herstellung von neuen 6,16-dimethylkortikoiden - Google Patents

Verfahren zur herstellung von neuen 6,16-dimethylkortikoiden Download PDF

Info

Publication number
DD214134A5
DD214134A5 DD83253117A DD25311783A DD214134A5 DD 214134 A5 DD214134 A5 DD 214134A5 DD 83253117 A DD83253117 A DD 83253117A DD 25311783 A DD25311783 A DD 25311783A DD 214134 A5 DD214134 A5 DD 214134A5
Authority
DD
German Democratic Republic
Prior art keywords
dione
dimethyl
pregnadiene
hydroxy
pregnene
Prior art date
Application number
DD83253117A
Other languages
German (de)
English (en)
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Michael Toepert
Hans Wendt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD214134A5 publication Critical patent/DD214134A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
DD83253117A 1982-07-19 1983-07-15 Verfahren zur herstellung von neuen 6,16-dimethylkortikoiden DD214134A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3227312A DE3227312A1 (de) 1982-07-19 1982-07-19 Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
DD214134A5 true DD214134A5 (de) 1984-10-03

Family

ID=6168986

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83253117A DD214134A5 (de) 1982-07-19 1983-07-15 Verfahren zur herstellung von neuen 6,16-dimethylkortikoiden

Country Status (23)

Country Link
US (2) US4555507A (fr)
EP (1) EP0100874B1 (fr)
JP (1) JPS5967298A (fr)
AT (1) ATE50780T1 (fr)
AU (1) AU1694183A (fr)
BG (2) BG43693A3 (fr)
CA (1) CA1312856C (fr)
DD (1) DD214134A5 (fr)
DE (2) DE3227312A1 (fr)
DK (1) DK162232C (fr)
ES (1) ES524238A0 (fr)
FI (1) FI832575A (fr)
GB (1) GB2124230A (fr)
GR (1) GR78902B (fr)
HU (1) HU191539B (fr)
IE (1) IE55771B1 (fr)
IL (1) IL69230A (fr)
NO (1) NO157453C (fr)
PH (1) PH19976A (fr)
PL (1) PL141537B1 (fr)
PT (1) PT76995B (fr)
RO (4) RO92856A (fr)
ZA (1) ZA835249B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3400188A1 (de) * 1984-01-02 1985-07-11 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 6(alpha),16(alpha)-dimethylkortikoide
DE3401680A1 (de) * 1984-01-16 1985-07-18 Schering AG, 1000 Berlin und 4709 Bergkamen 6(alpha),16ss-dimethylkortikoide
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5319115A (en) * 1987-08-25 1994-06-07 Cocensys Inc. Method for making 3α-hydroxy, 3β-substituted-pregnanes
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
DE3915951C1 (fr) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
EP0523132A1 (fr) * 1990-03-27 1993-01-20 Schering Corporation PROCEDE DE DESHYDRATATION DE 9$g(a)-HYDROXY STEROIDES
FR2701262B1 (fr) * 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
EP2556083A4 (fr) 2010-04-05 2013-12-04 Validus Biopharma Inc Modulateurs stéroïdes non hormonaux de nf- kappa b pour le traitement de maladies
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU75903A1 (fr) * 1976-09-29 1978-05-16
GB931224A (en) * 1958-10-01 1963-07-17 Merck & Co Inc Steroid compounds and their production
GB898295A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
US3054811A (en) * 1961-09-14 1962-09-18 Merck & Co Inc Ring a unsaturated 6, 16-dimethyl steroids of the pregnane series
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB1047519A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds
GB1544642A (en) * 1976-06-04 1979-04-25 Bristol Myers Co 9,11-epoxy steroids and synthesis of corticosteroids therefrom
DE2645105C2 (de) * 1976-10-04 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2715854A1 (de) * 1977-04-06 1978-10-19 Schering Ag Verfahren zur herstellung von 11alpha,21-dihydroxy-1,4-pregnadien- 3,20-dion-derivaten
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
DE2759135A1 (de) * 1977-12-30 1979-07-19 Lark Spa Neue steroidverbindungen und deren herstellung und verwendung
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2803661A1 (de) * 1978-01-25 1979-07-26 Schering Ag Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung
DE2901561A1 (de) * 1979-01-12 1980-07-31 Schering Ag Verfahren zur herstellung von 11 beta, 17 alpha, 21-trihydroxy-4-pregnen-3,20dion-derivaten
EP0054786B1 (fr) * 1980-12-23 1985-03-20 Schering Aktiengesellschaft Dérivés de la 6-alpha-méthyl hydrocortisone, leur préparation et leur utilisation
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Also Published As

Publication number Publication date
EP0100874A2 (fr) 1984-02-22
ZA835249B (en) 1984-03-28
DK329183D0 (da) 1983-07-18
PT76995A (de) 1983-08-01
DK329183A (da) 1984-01-20
NO157453C (no) 1988-03-23
EP0100874B1 (fr) 1990-03-07
ATE50780T1 (de) 1990-03-15
RO92855A (fr) 1987-11-30
BG43693A3 (en) 1988-07-15
DE3381291D1 (de) 1990-04-12
GB2124230A (en) 1984-02-15
ES8403929A1 (es) 1984-04-16
GB8319363D0 (en) 1983-08-17
RO92856A (fr) 1987-11-30
FI832575A0 (fi) 1983-07-14
EP0100874A3 (en) 1985-04-17
IE55771B1 (en) 1991-01-16
BG43692A3 (en) 1988-07-15
US4701451A (en) 1987-10-20
IL69230A0 (en) 1983-11-30
NO157453B (no) 1987-12-14
AU1694183A (en) 1984-01-26
DK162232C (da) 1992-03-02
GR78902B (fr) 1984-10-02
ES524238A0 (es) 1984-04-16
CA1312856C (fr) 1993-01-19
JPS5967298A (ja) 1984-04-16
PL141537B1 (en) 1987-08-31
RO92853B1 (ro) 1987-12-01
US4555507A (en) 1985-11-26
JPH0415239B2 (fr) 1992-03-17
RO92853A2 (fr) 1987-11-30
HU191539B (en) 1987-03-30
DK162232B (da) 1991-09-30
NO832609L (no) 1984-01-20
FI832575A (fi) 1984-01-20
IL69230A (en) 1988-07-31
IE831658L (en) 1984-01-19
RO92854A (fr) 1987-11-30
PH19976A (en) 1986-08-26
PL243082A1 (en) 1984-11-19
PT76995B (de) 1986-01-09
DE3227312A1 (de) 1984-01-19

Similar Documents

Publication Publication Date Title
EP0072547B1 (fr) Dérivés de 6-alpha-méthyl prednisolone, leur préparation et leur utilisation
DD214134A5 (de) Verfahren zur herstellung von neuen 6,16-dimethylkortikoiden
DD227966A5 (de) Verfahren zur herstellung neuer carbonsaeureester
CH533094A (de) Verfahren zur Herstellung neuer Steroide
EP0110041B1 (fr) 6-Alpha méthyl corticoides, leur préparation et leur utilisation
EP0072546B1 (fr) Dérivés d'hydrocortisone, leur préparation et leur utilisation
DE3102397A1 (de) 17(alpha)-acyloxy-5(beta)-corticoide und 17(alpha)-acyloxy-5(alpha)-corticoide
US4777165A (en) 6α, 16β-dimethyl corticoids and their anti-inflammatory use
EP0149222A2 (fr) 6-Alpha, 16 alpha-diméthylcorticoides
DE1518994A1 (de) Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden
EP0003341B1 (fr) Prégnanes substitués en positions 11 et 17, leur préparation et leur utilisation pour la préparation de compositions pharmaceutiques
DE2340656A1 (de) Steroidverbindungen
DE2365992C3 (de) 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
EP0164298A2 (fr) 6-Alpha-méthyl-D-homo-corticoides
DE69213680T2 (de) Neues Verfahren zur Herstellung von 20-Oxo, 17-Alpha, 21-Dihydroxy Derivaten von Pregnan und neue Zwischenprodukte dafür
DE2516937A1 (de) 6-azido-4,6-pregnadien eckige klammer auf 3,2-c eckige klammer zu pyrazole und verfahren zu ihrer herstellung
EP0049783B1 (fr) D-homo corticoides, leur préparation et leur utilisation
DE2508136C3 (de) Neue Steroide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE3143757A1 (de) Neue kortikoide, ihre herstellung und verwendung
DE2645105A1 (de) Neue derivate des 9-chlorprednisolons
DE2809732A1 (de) Neue derivate des 9-fluorprednisolons
DD209635A5 (de) Verfahren zur herstellung von 11beta-chlor-steroiden
EP0112467A1 (fr) Dérivés de 6 alpha méthylprednisolone, leur préparation et leur utilisation
DE2855465A1 (de) Neue kortikoide, verfahren zu ihrer herstellung, ihre verwendung und diese kortikoide enthaltende pharmazeutische praeparate
DE2141127A1 (de) Neues verfahren zur herstellung wertvoller steroidderivate und zwischenprodukte fuer dieselben

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee